ID: ALA4176533

Max Phase: Preclinical

Molecular Formula: C17H17N3O3

Molecular Weight: 311.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(=O)C1=NC2C=CC=CN2C1c1cccc(CCC(=O)O)c1

Standard InChI:  InChI=1S/C17H17N3O3/c18-17(23)15-16(20-9-2-1-6-13(20)19-15)12-5-3-4-11(10-12)7-8-14(21)22/h1-6,9-10,13,16H,7-8H2,(H2,18,23)(H,21,22)

Standard InChI Key:  BIWNPKVGUHOHQH-UHFFFAOYSA-N

Associated Targets(Human)

Group X secretory phospholipase A2 219 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 311.34Molecular Weight (Monoisotopic): 311.1270AlogP: 1.40#Rotatable Bonds: 5
Polar Surface Area: 95.99Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.12CX Basic pKa: 2.20CX LogP: 2.11CX LogD: -0.88
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.86Np Likeness Score: 0.15

References

1. Knerr L, Giordanetto F, Nordberg P, Pettersen D, Selmi N, Beisel HG, de la Motte H, Olsson T, Perkins TDJ, Herslöf M, Månsson Å, Dahlström M, Starke I, Broddefalk J, Saarinen G, Klingegård F, Hurt-Camejo E, Rosengren B, Brengdahl J, Jansen F, Rohman M, Sandmark J, Hallberg K, Åkerud T, Roth RG, Ahlqvist M..  (2018)  Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A2 Type X (sPLA2-X) Inhibitors.,  (7): [PMID:30034585] [10.1021/acsmedchemlett.7b00505]

Source